These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

126 related items for PubMed ID: 18379981

  • 1. Urokinase lock or flush solution for prevention of bloodstream infections associated with central venous catheters for chemotherapy: a meta-analysis of prospective randomized trials.
    Kethireddy S, Safdar N.
    J Vasc Access; 2008; 9(1):51-7. PubMed ID: 18379981
    [Abstract] [Full Text] [Related]

  • 2. Use of vancomycin-containing lock or flush solutions for prevention of bloodstream infection associated with central venous access devices: a meta-analysis of prospective, randomized trials.
    Safdar N, Maki DG.
    Clin Infect Dis; 2006 Aug 15; 43(4):474-84. PubMed ID: 16838237
    [Abstract] [Full Text] [Related]

  • 3. The risk of bloodstream infection in adults with different intravascular devices: a systematic review of 200 published prospective studies.
    Maki DG, Kluger DM, Crnich CJ.
    Mayo Clin Proc; 2006 Sep 15; 81(9):1159-71. PubMed ID: 16970212
    [Abstract] [Full Text] [Related]

  • 4. A vancomycin-heparin lock solution for prevention of nosocomial bloodstream infection in critically ill neonates with peripherally inserted central venous catheters: a prospective, randomized trial.
    Garland JS, Alex CP, Henrickson KJ, McAuliffe TL, Maki DG.
    Pediatrics; 2005 Aug 15; 116(2):e198-205. PubMed ID: 15995005
    [Abstract] [Full Text] [Related]

  • 5. Interventions other than anticoagulants and systemic antibiotics for prevention of central venous catheter-related infections in children with cancer.
    Arora RS, Roberts R, Eden TO, Pizer B.
    Cochrane Database Syst Rev; 2010 Dec 08; (12):CD007785. PubMed ID: 21154387
    [Abstract] [Full Text] [Related]

  • 6. Efficacy of urokinase in maintaining patency of hemodialysis catheters: A meta-analysis.
    Deng J, Luo W, Zhang W, Xiong S, Wang L.
    Clin Nephrol; 2024 Oct 08; 102(4):212-222. PubMed ID: 38994593
    [Abstract] [Full Text] [Related]

  • 7. The promise of novel technology for the prevention of intravascular device-related bloodstream infection. II. Long-term devices.
    Crnich CJ, Maki DG.
    Clin Infect Dis; 2002 May 15; 34(10):1362-8. PubMed ID: 11981732
    [Abstract] [Full Text] [Related]

  • 8. Weekly prophylactic urokinase instillation in tunneled central venous access devices.
    Ray CE, Shenoy SS, McCarthy PL, Broderick KA, Kaufman JA.
    J Vasc Interv Radiol; 1999 May 15; 10(10):1330-4. PubMed ID: 10584647
    [Abstract] [Full Text] [Related]

  • 9. Thromboprophylaxis in cancer patients with central venous catheters. A systematic review and meta-analysis.
    Chaukiyal P, Nautiyal A, Radhakrishnan S, Singh S, Navaneethan SD.
    Thromb Haemost; 2008 Jan 15; 99(1):38-43. PubMed ID: 18217132
    [Abstract] [Full Text] [Related]

  • 10. Evidence-based criteria for the choice and the clinical use of the most appropriate lock solutions for central venous catheters (excluding dialysis catheters): a GAVeCeLT consensus.
    Pittiruti M, Bertoglio S, Scoppettuolo G, Biffi R, Lamperti M, Dal Molin A, Panocchia N, Petrosillo N, Venditti M, Rigo C, DeLutio E.
    J Vasc Access; 2016 Nov 02; 17(6):453-464. PubMed ID: 27516141
    [Abstract] [Full Text] [Related]

  • 11. Low-dose urokinase infusions to treat fibrinous obstruction of venous access devices in cancer patients.
    Horne MK, Mayo DJ.
    J Clin Oncol; 1997 Jul 02; 15(7):2709-14. PubMed ID: 9215844
    [Abstract] [Full Text] [Related]

  • 12. Urokinase-containing locking solution in the prevention of dialysis catheter dysfunction: a double blind randomized controlled trial.
    Bonkain F, Van Hulle F, Janssens P, Catalano C, Allamani M, Stolear JC, Vandervelde D, Libertalis M, Treille S, Couttenye MM, Dhondt A, Van Biesen W, Fils JF, Tielemans C, Wissing KM.
    J Vasc Access; 2017 Sep 11; 18(5):436-442. PubMed ID: 28623638
    [Abstract] [Full Text] [Related]

  • 13. Urokinase: new indication. Thrombosed venous and dialysis catheters: when heparin fails. Urokinase clears about 75% of thrombosed venous catheters intended for long-term use with a dose-related increase in the bleeding risk.
    Prescrire Int; 2009 Jun 11; 18(101):118. PubMed ID: 19637430
    [No Abstract] [Full Text] [Related]

  • 14. Efficacy of urokinase lock to treat thrombotic dysfunction of tunneled hemodialysis catheters: A retrospective cohort study.
    Van Hulle F, Bonkain F, De Clerck D, Aerden D, Vanwijn I, Tielemans C, Wissing KM.
    J Vasc Access; 2019 Jan 11; 20(1):60-69. PubMed ID: 29893163
    [Abstract] [Full Text] [Related]

  • 15. A randomized, controlled trial of a new vascular catheter flush solution (minocycline-EDTA) in temporary hemodialysis access.
    Bleyer AJ, Mason L, Russell G, Raad II, Sherertz RJ.
    Infect Control Hosp Epidemiol; 2005 Jun 11; 26(6):520-4. PubMed ID: 16018426
    [Abstract] [Full Text] [Related]

  • 16. Antimicrobial lock solutions for the prevention of infections associated with intravascular catheters in patients undergoing hemodialysis: systematic review and meta-analysis of randomized, controlled trials.
    Yahav D, Rozen-Zvi B, Gafter-Gvili A, Leibovici L, Gafter U, Paul M.
    Clin Infect Dis; 2008 Jul 01; 47(1):83-93. PubMed ID: 18498236
    [Abstract] [Full Text] [Related]

  • 17. Low-molecular-weight heparin and calcium heparin in thrombosis prophylaxis in patients with percutaneous arterial and venous ports for colorectal liver metastases.
    Zanon C, Bortolini M, Chiappino I.
    Tumori; 2005 Jul 01; 91(6):477-80. PubMed ID: 16457145
    [Abstract] [Full Text] [Related]

  • 18. Interventions for restoring patency of occluded central venous catheter lumens (Review).
    van Miert C, Hill R, Jones L.
    Evid Based Child Health; 2013 Mar 07; 8(2):695–749. PubMed ID: 24482900
    [No Abstract] [Full Text] [Related]

  • 19. Ethanol lock therapy (E-Lock) in the prevention of catheter-related bloodstream infections (CR-BSI) after major heart surgery (MHS): a randomized clinical trial.
    Pérez-Granda MJ, Barrio JM, Muñoz P, Hortal J, Rincón C, Rabadán PM, Pernia MS, Bouza E.
    PLoS One; 2014 Mar 07; 9(3):e91838. PubMed ID: 24675993
    [Abstract] [Full Text] [Related]

  • 20. Salvage of long-term central venous catheters during an outbreak of Pseudomonas putida and Stenotrophomonas maltophilia infections associated with contaminated heparin catheter-lock solution.
    Souza Dias MB, Habert AB, Borrasca V, Stempliuk V, Ciolli A, Araújo MR, Costa SF, Levin AS.
    Infect Control Hosp Epidemiol; 2008 Feb 07; 29(2):125-30. PubMed ID: 18179367
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.